Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study

Harm Reduction Journal

Volumn 2, Issue , 2005, Pages

  Vazirian, Mohsen ^a,b   Nassirimanesh, Bijan ^c   Zamani, Saman ^d   Ono Kihara, Masako ^d   Kihara, Masahiro ^d   Ravari, Shahrzad Mortazavi ^d   Gouya, Mohammad Mehdi ^a  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Persepolis Society   (Iran)

^d KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMMUNITY CARE; CONFIDENCE INTERVAL; EPIDEMIC; EXPOSURE; FEMALE; HEALTH BEHAVIOR; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RATE; INTRAVENOUS DRUG ABUSE; IRAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEEDLE; RISK ASSESSMENT; RISK REDUCTION; SYRINGE;

EID: 27644433131     PISSN: 14777517     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-2-19     Document Type: Article

References (11)

1. UNAIDS/UNICEF/WHO. Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections- Islamic Republic of Iran, 2004 Update. Geneva; 2004.
2. Center for Disease Management, Ministry of Health and Medical Education. AIDS/HIV Surveillance Report (December 2004). Tehran, Iran, 2004.
3. Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M, Razzaghi EM, Ichikawa S: Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 2005, 19(7):709-716
4. Vazirian M. Review of drug demand reduction programs in Iran: Advices for development and strategic planning. Social Welfare Quarterly (in Persian) 2003; 9:145-201.
5. World Health Organization: Evidence for Action: Effectiveness of Community-Based Outreach in Preventing HIV/AIDS among Injecting Drug Users. Geneva; 2004.
6. Watters JK, Estilo MJ, Clark GL, Lorvick J: Syringe and needle exchange as HIV/AIDS prevention for injection drug use. JAMA. 1994, 271: 115-20
7. Donoghoe MC, Stimson GV, Dolan K, Alldritt L. Changes in HIV risk behavior in clients of syringe-exchange schemes in England and Wales. AIDS 1989, 3: 267-272
8. Peak A, Rana S, Maharjan SH, Jolley D, Crofts N: Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme. AIDS, 1995; 9:1067-1070
9. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR: The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS, 2000, 14: 605-611
10. Crofts N, Caruana S, Bowden S, and Kerger M: Minimising harm from hepatitis C virus needs better strategies. British Medical Journal 2000, 321: 899.
11. Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, Des Jarlais DC: Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med 1996, 42(5): 691-703.